Regulatory Articles. App Notes, Case Studies. & White Papers
-
Navigating IND Submissions In China
Lonza Biologics recently presented a webinar on how to navigate the complexities of submitting a clinical trial application in China.
-
The Importance Of Assessing And Mitigating Immunogenicity Potential
Immunogenicity assessment is an area where "standard" in vivo toxicology assessments might lack clinical relevance. Get an expert view on early immunosafety assessment challenges and risk mitigation strategies.
-
Soluble Versus Insoluble Expression In Microbial Fermentation
Expression of inclusion bodies has historically suffered a bad reputation in the industry. So, how do these two routes, soluble and insoluble, compare in terms of their advantages and challenges?
-
A Stepwise Approach To CMC Planning For A Biologics License Application
Lonza understands the challenges of designing a CMC strategy and has developed a structured and stepwise approach to planning that is tailored to our customers’ product, process, and risk tolerance.
-
A 15-Minute Guide To Compliant Document Management For Life Sciences
Life Sciences quality and manufacturing organizations face three critical industry forces: increasingly stringent regulation; globalization; and virtualization of supply networks.
-
A 15 Minute Guide To Efficient And Compliant Management Of GMP Controlled Documents
Life Sciences quality and manufacturing organizations face three critical industry forces: increasingly stringent regulation; globalization; and virtualization of supply networks.
-
Best Practices For Effective Quality Documentation Processes
Developing a quality and compliance posture is a tall order. Explore the trends that successful quality and compliance teams adopt to keep pace with the speed of discovery.
-
Overcome Complex Protein Challenges With Optimized Expression
Realizing the potential of next-generation molecules calls on appropriate expression technologies and development processes that can facilitate their path to market.